(Reuters) - Johnson & Johnson (NYSE: JNJ ) has sued divisions of Cigna (NYSE: CI ), accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its pricier drugs, The Wall Street Journal reported on Friday.